Exploration of the Impact of Preferred Drug Lists on Hospital and Physician Visits and the Costs to MedicaidByMatthew M. Murawski, RPh, PhD,Tamer Abdelgawad, MAJanuary 15th 2005
Medicaid Prescription Drug Access Restrictions: Exploring the Effect on Patient Persistence With Hypertension MedicationsByJerome Wilson, PhD,Kirsten Axelsen, MS,Simon Tang, MPHJanuary 15th 2005
Physicians' Prescribing Responses to a Restricted Formulary: The Impact of Medicaid Preferred Drug Lists in Illinois and LouisianaBySuchin Virabhak, PhD,Judith A. Shinogle, PhDJanuary 15th 2005
The Effect of Access Restrictions on the Vintage of Drugs Used by Medicaid EnrolleesByFrank R. Lichtenberg, PhDJanuary 15th 2005
Why Worry About Restricting Access to Medicines in Medicaid?ByValentine J. Burroughs, MD, MBAJanuary 15th 2005
Exploring the Potential Link Between Medicaid Access Restrictions, Physician Location, and Health DisparitiesByAlvin Headen, PhD,Neal Masia, PhDJanuary 15th 2005
